Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - moxifloxacinum - compresse rivestite con film - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum 436.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, lactosum monohydricum 68 mg, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium 2.79 mg. - malattie infettive - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - moxifloxacinum - compresse rivestite con film - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum monohydricum, cellulosum microcristallinum, maydis amylum, carboxymethylamylum natricum a corresp. natrium max. 0.84 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, e 171, macrogoli stearas, e 172 (rubrum), e 120, pro compresso obducto. - malattie infettive - synthetika

Zwitserland - Frans - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - moxifloxacinum - solution à diluer pour perfusion - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum 436 mg, natrii chloridum, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 250 ml, natrium 813 mg. - les maladies infectieuses - synthetika

Zwitserland - Frans - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - moxifloxacinum - comprimés pelliculés - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum 436.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, lactosum monohydricum 68 mg, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium 2.79 mg. - les maladies infectieuses - synthetika

Zwitserland - Duits - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - moxifloxacinum - filmtabletten - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum monohydricum, cellulosum microcristallinum, maydis amylum, carboxymethylamylum natricum a corresp. natrium max. 0.84 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, e 171, macrogoli stearas, e 172 (rubrum), e 120, pro compresso obducto. - infektionskrankheiten - synthetika

Zwitserland - Frans - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - moxifloxacinum - comprimés pelliculés - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum monohydricum, cellulosum microcristallinum, maydis amylum, carboxymethylamylum natricum a corresp. natrium max. 0.84 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, e 171, macrogoli stearas, e 172 (rubrum), e 120, pro compresso obducto. - les maladies infectieuses - synthetika

Tsjechië - Tsjechisch - SUKL (Státní ústav pro kontrolu léčiv)

aurovitas, spol. s r.o., praha array - 5562 moxifloxacin-hydrochlorid - potahovaná tableta - 400mg - moxifloxacin

Tsjechië - Tsjechisch - SUKL (Státní ústav pro kontrolu léčiv)

vivanta generics s.r.o., praha array - 5562 moxifloxacin-hydrochlorid - potahovaná tableta - 400mg - moxifloxacin

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - moxifloxacinum - collirio - moxifloxacinum 5 mg ut moxifloxacini hydrochloridum 5.45 mg, natrii chloridum, acidum boricum, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, ad solutionem pro 1 ml. - infezioni batteriche della parte anteriore augenabschnittes - synthetika

Zwitserland - Italiaans - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - moxifloxacinum - soluzione per infusione - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 250 ml corresp. natrium 787.2 mg. - malattie infettive - synthetika